0

The Effect of Optivite for Women on Premenstrual Tension Syndromes: Blood Chemistry and Serum Steroid Levels During the Mid-Luteal Phase

Fuchs N et al., 1985

Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 23(6), 667-670

Source

Abstract

Plasma and erythrocyte magnesium were measured in 105 patients with premenstrual syndrome (PMS) using a simple atomic absorption spectroscopy method. The erythrocyte magnesium concentration for the patients with PMS was significantly lower than that of a normal population. The plasma magnesium did not show this difference. The significance of this apparent cellular deficiency of magnesium is discussed.

Topics

Menstrual Cycle > Disorders > PMDDMenstrual Cycle > Biomarkers > HormonalReproductive Endocrinology > Luteal Phase > Deficiency
magnesium deficiency premenstrual syndrome, erythrocyte magnesium pms, luteal phase magnesium levels, nutritional deficiency menstrual disorders, cellular magnesium deficiency pms, blood chemistry premenstrual tension, micronutrient status menstrual cycle, magnesium supplementation pms treatment, mid-luteal phase biochemistry, optivite premenstrual syndrome, mineral deficiency menstrual symptoms

Cite this article

Fuchs, N., Hakim, M., & Abraham, G. E. (1985). The Effect of Optivite for Women on Premenstrual Tension Syndromes: Blood Chemistry and Serum Steroid Levels During the Mid-Luteal Phase. *Annals of Clinical Biochemistry: International Journal of Laboratory Medicine*, *23*(6), 667-670. https://doi.org/10.1177/000456328602300607

Related articles